Terragen Holdings Limited announced the following change to its Board. Dr. Paul Schober has informed the Chairman of his intention to retire from the Board at the end of February 2022. Dr. Schober will continue to be involved in the company in an advisory capacity, working with the Terragen Science Team.

Dr. Schober has had a long association with Terragen, joining the Board of Terragen in June 2017 and he was the Chairman when the company first listed in December 2019. Chairman Travis Dillon and the Board thank Paul for his valuable contribution to Terragen's growth and wish him well for the future.